La Caisse and Archimed Diagnostics buy French company Stago
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Digital Subscription
One year of digital access for only $1.44 a week*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $5.77 plus GST every four weeks. After 52 weeks, price increases to the regular rate of $19.95 plus GST every four weeks. Offer available to new and qualified returning subscribers only. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
MONTREAL – Quebec investment manager La Caisse and health-care private equity firm Archimed Diagnostics have bought Stago, a French company specialized in the analysis of blood coagulation issues.
Financial terms of the agreement with the founding Viret family were not immediately available.
Stago sells its products in 115 countries and last year had revenue of about $880 million.
Martin Longchamps, head of private equity and private credit at La Caisse, said Stago is a recognized leader in blood coagulation analysis.
Stago, founded in 1945, develops and manufactures hemostasis equipment and reagents.
Stago’s leadership team is taking a minority stake as part of the deal.
This report by The Canadian Press was first published April 29, 2026.